3D Endoanal Ultrasound and Anal Fistula (UFU)
|ClinicalTrials.gov Identifier: NCT03937752|
Recruitment Status : Completed
First Posted : May 6, 2019
Last Update Posted : March 30, 2020
|Condition or disease||Intervention/treatment|
|Anal Fistula||Other: 3D endodanal ultrasound|
|Study Type :||Observational|
|Actual Enrollment :||95 participants|
|Official Title:||The Role of 3D Endoanal Ultrasound in Management of Anal Fistulas|
|Actual Study Start Date :||April 1, 2018|
|Actual Primary Completion Date :||March 26, 2020|
|Actual Study Completion Date :||March 26, 2020|
Patients with anal fistulas, no previous fistula procedures. Ultrasound investigation done as a part of surgical treatment, such as loose seton or fistulotomy.
Other: 3D endodanal ultrasound
Endoanal ultrasound performed with two different transducers preoperatively during a fistula treatment procedure.
Other Name: 3D endoanal ultrasonography
- Fistula position [ Time Frame: Day 1 ]Dorsal? Ventral? Lateral - right or left?
- Fistula level [ Time Frame: Day 1 ]Level I-IV (how much of the sphincter is affected?)
- Fistula length [ Time Frame: Day 1 ]Shorter or longer than 3 cm?
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03937752
|Pelvic Floor Centre|
|Principal Investigator:||Ursula Aho Fält, MD||Region Skane|